The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice

Author： Garcia-Saenz-de-Sicilia Mauricio   Mukherjee Sandeep  

Publisher： Informa Healthcare

ISSN： 1751-2433

Source： Expert Review of Clinical Pharmacology, Vol.5, Iss.5, 2012-09, pp. : 587-593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recurrent Hepatitis C After Liver Transplantation

By Mukherjee Sandeep  

Anti-Infective Agents, Vol. 10, Iss. 1, 2012-01 ,pp. : 34-40

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Hepatitis C Infection after Liver Transplantation

By Alsatie Mazen   Chalasani Naga   Kwo Paul Y.  

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 871-885

Adis International

Access to resources Recommend Favorite

Recurrent Hepatitis C After Liver Transplantation

By  

Anti-Infective Agents, Vol. 10, Iss. 1, 2012-01 ,pp. : 34-40

Bentham Science Publishers

Access to resources Recommend Favorite

Natural History, Risk Factors and Management of Hepatitis C After Liver Transplantation

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 2, 2012-04 ,pp. : 124-130

Bentham Science Publishers

Access to resources Recommend Favorite

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice

By Bruce R Douglas   Moody David E   Altice Frederick L   Gourevitch Marc N   Friedland Gerald H  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 3, 2013-05 ,pp. : 249-269

Informa Healthcare

Access to resources Recommend Favorite